Does OSIMERTINIB Cause Lung neoplasm malignant? 202 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Lung neoplasm malignant have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.7% of all adverse event reports for OSIMERTINIB.
202
Reports of Lung neoplasm malignant with OSIMERTINIB
0.7%
of all OSIMERTINIB reports
80
Deaths
27
Hospitalizations
How Dangerous Is Lung neoplasm malignant From OSIMERTINIB?
Of the 202 reports, 80 (39.6%) resulted in death, 27 (13.4%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which OSIMERTINIB Alternatives Have Lower Lung neoplasm malignant Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN